Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rikita I. Hatia"'
Autor:
Iman Moussa, Rena S. Day, Ruosha Li, Ahmed Kaseb, Prasun K. Jalal, Carrie Daniel‐MacDougall, Rikita I. Hatia, Ahmed Abdelhakeem, Asif Rashid, Yun Shin Chun, Donghui Li, Manal M. Hassan
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7308-7319 (2021)
Abstract Background and Aims The role of dietary fat consumption in the etiology of hepatocellular carcinoma (HCC) remains unclear. We investigated the associations of total fat and fatty acids with risk of HCC among US adults in a hospital‐based c
Externí odkaz:
https://doaj.org/article/081df2496895433c9c1f84d4abe4ac7c
Autor:
Iman Moussa, Rena S. Day, Ruosha Li, Xianglin L. Du, Ahmed O. Kaseb, Prasun K. Jalal, Carrie Daniel-MacDougall, Rikita I. Hatia, Ahmed Abdelhakeem, Asif Rashid, Yun Shin Chun, Donghui Li, Manal M. Hassan
Publikováno v:
Nutrients, Vol 13, Iss 6, p 2011 (2021)
The objective of this study was to assess the association between dietary patterns and risk of hepatocellular carcinoma (HCC) among US adults in a hospital-based case-control study. We analyzed data from 641 cases and 1002 controls recruited at The U
Externí odkaz:
https://doaj.org/article/164f5cfebcfb4df184984936c15eb4f9
Autor:
Yehia I. Mohamed, Dan G. Duda, Muhammad O. Awiwi, Sunyoung S. Lee, Lina Altameemi, Lianchun Xiao, Jeffrey S. Morris, Robert A. Wolff, Khaled M. Elsayes, Rikita I. Hatia, Aliya Qayyum, Shadi M. Chamseddine, Asif Rashid, James C. Yao, Armeen Mahvash, Manal M. Hassan, Hesham M. Amin, Ahmed Omar Kaseb
Publikováno v:
Oncotarget. 13
Hepatocellular carcinoma (HCC) has limited systemic therapy options when discovered at an advanced stage. Thus, there is a need for accessible and minimally invasive biomarkers of response to guide the selection of patients for treatment. This study
Autor:
Grace W. Hamadeh, Aishwarya Lanka, Akram Shalaby, Rikita I. Hatia, Ahmed Shalaby, Adam Khalifa, Donghui Li, Milind Javle, Manal Hassan
Publikováno v:
Gastroenterology. 162:S-751
Autor:
Chong Gee Teo, D. Robert Dufour, Rikita I. Hatia, Michael K. Chapko, John W. Ward, Jan Drobeniuc
Publikováno v:
Hepatology. 62:1396-1404
Six strategies for identifying hepatitis C virus (HCV) viremia, involving testing for HCV antibody (HCVAb) followed by a nucleic acid test (NAT) for HCV RNA when the antibody test is positive, are compared. Decision analysis was used to determine mea
Publikováno v:
Hepatology. 62:101-110
The extent of provider-to-patient hepatitis C virus (HCV) transmission from diversion, self-injection, and substitution (“tampering”) of anesthetic opioids is unknown. To quantify the contribution of opioid tampering to nosocomial HCV outbreaks,